Navigation Links
Protein deficiency leads to faster fat burning in mice, study shows
Date:3/12/2008

COLUMBUS, Ohio Researchers have developed a new, lean mouse with characteristics suggesting that someday, using medication to manipulate a specific protein in humans could emerge as a strategy to treat obesity and disorders associated with excess weight, such as diabetes and metabolic syndrome.

To create the hybrid, scientists crossed mice deficient in protein kinase C beta (PKCB) with the C57 black mouse, a common animal used in research for studying diabetes and obesity.

These animals can eat more than normal. And they have less fat than normal. Thats a dream come true if it can be extended to human beings, said Kamal Mehta, senior author of the study and a professor of molecular and cellular biochemistry at Ohio State University.

He noted, however, that an appropriate therapy for humans would take years to develop.

At first glance, compared to mice with no deficiency, these new hybrid mice were smaller and leaner. And when the researchers looked under their skin, they saw the mice had less fat distribution in the skin itself and less fat tissue overall. They also had less fat in their livers and muscles. The fat cells they did have were smaller than fat cells in other mice.

And despite the propensity for obesity from their original genes, the new mice lost weight while eating up to 30 percent more food than other mice. This means their lower weight was not caused by less eating, suggesting the protein deficiency corrected for the obesity tendencies by increasing the hybrids ability to burn fat, said Mehta, an investigator in Ohio States Davis Heart and Lung Research Institute.

The research is published in a recent issue of the Journal of Biological Chemistry.

Based on his previous research on the role of PKCB in metabolism, Mehta expected a deficiency of the protein to affect how the body processes triglycerides, or fat stored in body tissue.

The bottom line is we were the first to s
'/>"/>

Contact: Kamal Mehta
Mehta.80@osu.edu
614-688-8451
Ohio State University
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. University of Pittsburgh researchers crack code of 3-D structure in key metabolic protein
2. UCF researchers discover a new protein family implicated in inflammatory diseases
3. Scientists Engineer Protein That Could Battle Strep
4. New protein discovery helps researchers understand autoimmune diseases
5. Protein in Human Embryonic Stem Cells Controls Malignant Tumor Cells
6. Sticky blood protein yields clues to autism
7. Penn scientists find a protein that inhibits Ebola from reaching out to infect neighboring cells
8. Embryonic Stem Cell Protein Inhibits Melanoma
9. Protein in embryonic stem cells control malignant tumor cells
10. Novel mechanism found that may boost impaired function of leukemia protein
11. Cancer-related protein may play key role in Alzheimers disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)...srupt normal development, mouse study finds , ... few glasses of wine over a short period in early ...chers from the Medical College of Georgia. , T...affects one in 1,000 babies, include facial malfor...ye openings, and a short nose. Researchers are inv...
(Date:8/29/2008)...-FirstCall/ -- Landauer, Inc. (NYSE:,LDR) announce...ular,quarterly cash dividend of $0.50 per share fo...will be paid on October 3, 2008, to shareholders o... Landauer is the leading provider of analytical se... radiation exposure. For more than 50 years,the C...
(Date:8/29/2008)...Telemedicine Encounter Management Systems (TEMS) t... possible solution to national health care problem...WEB) August 29, 2008 -- If there has been any one ...Democratic National Convention it has been the par...lth care issues., , ,Our Democratic leadership rec...
(Date:8/28/2008)...ia led to daytime tiredness, symptoms of depressio... -- Older adults who live with and provide direct ...ve significantly worse sleep than other older adul... 31 caregivers and 102 noncaregivers, ages 60 to 8...t than non-caregivers and took about 10 minutes lo...
Breaking Medicine News(10 mins):Health News:Alcohol in Early Pregnancy May Prompt Fetal Cell Death 2Health News:AMD Global Telemedicine Inc. Invited to Attend Democratic National Convention 2Health News:Older Caregivers Prone to Worse Sleep Patterns 2
...he University of Pennsylvania’s School of Medicine...gene that it is possible //to inhibit bone decay w...is concept may lead to drug treatments for osteopo...won Choi, PhD, professor of Pathology and Laborato...
...ommon form of brewer's yeast, University of Wiscon...ions of a key protein// that allow it to act as a ...nes gene activity and that, when malfunctioning in...rological disorders. The work, published in the De...
...o drug delivery has been achieved. This is made po...stable glass made from organic material.// It can...l Science has reported the advanced processing by ...son and the National Institute of Standards and Te...
...ursor has been found to be effective to reduce tum...vels of human epidermal growth factor receptor (HE...igh levels of HER2.This is presumed to be the feat...to many treatments including chemotherapy drugs. ...
Other Medicine News:Health News:Targeting a Single Gene Could Inhibit Bone Decay and Stimulate Bone Growth 2Health News:From a Lowly Yeast, Researchers Divine a Clue to Human Disease 2Health News:Drugs Delivery Revolutionized by Extremely Stable Glass 2Health News:Vitamin E Precursor Alpha-TOS Found Effective Against Breast Cancer Cells 2
(Date:8/27/2008)...2 trial, expected by mid-2009 - - Data from secon..., ROCKVILLE, Md., Aug. 27 /PRNewswire-FirstCall/ ...day announced it has completed enrollment,and init...Phase 3,randomized clinical trials of LymphoStat-B...upus erythematosus (SLE). Belimumab is being devel...
(Date:8/26/2008)... safely six weeks following surgical,treatment, R...Six weeks following,bunion surgery, most patients,...back behind the wheel of a car again. A study publ...one and Joint Surgery ( http://www.jbjs.org/ ),als...ents who underwent a,first metatarsal osteotomy (a...
(Date:8/26/2008)...eros Corporation today announced the,publication o...gating,OMS103HP in arthroscopic anterior cruciate ... an investigational drug product that is added to,...o improve postoperative,knee function and motion, ...rlier return to work. The article titled "Novel Dr...
(Date:8/25/2008)...ire/ -- Anthera Pharmaceuticals,Inc., a privately ...lammatory drugs, today announced the initiation of...s with Near-term Cardiovascular,Inflammation Suppr...act of,varespladib when administered to patients w... event., The FRANCIS trial is designed to assess ...
Breaking Medicine Technology:Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 2Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 3Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 4Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 5Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 6Braking After Bunion Surgery 2Braking After Bunion Surgery 3Omeros Announces Publication of Clinical Results for OMS103HP in Arthroscopy: The Journal of Arthroscopic and Related Surgery 2Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial 2Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial 3Capsule endoscopy turning up undiagnosed cases of Crohns disease 3774 1Capsule endoscopy turning up undiagnosed cases of Crohns disease 3774 2UD named a regional research participant in National Children 26 23146 3Bs Study 819 1UD named a regional research participant in National Children 26 23146 3Bs Study 819 2MIT 3A blood may help us think 816 1MIT 3A blood may help us think 816 2Chloroplast f and m Thioredoxins Discovered in Nonphotosynthetic Tissues 815 1Chloroplast f and m Thioredoxins Discovered in Nonphotosynthetic Tissues 815 2Chloroplast f and m Thioredoxins Discovered in Nonphotosynthetic Tissues 815 3
...mic Analyses of School and Daycare Study Outcomes ...e Cost Savings for,Community at Large, TORONTO..., Inc.,announced today research results showing ...Live, Intranasal) in daycare and school,settings... Economic,analyses applied to outcomes observed ...
...entific Presentation for Pristiq Occurs at the 55t...of Obstetricians and,Gynecologists, COLLEGEVILLE, ...Pharmaceuticals, a division of Wyeth , presented r...ristiq(TM) (desvenlafaxine) for,the treatment of m...and night sweats) associated with menopause. These...
Other Medicine Technology:Data Show FluMist May Reduce Seasonal Influenza Burden Among,Children in School, Daycare Settings 2Data Show FluMist May Reduce Seasonal Influenza Burden Among,Children in School, Daycare Settings 3Data Show FluMist May Reduce Seasonal Influenza Burden Among,Children in School, Daycare Settings 4Data Show FluMist May Reduce Seasonal Influenza Burden Among,Children in School, Daycare Settings 5Data Show FluMist May Reduce Seasonal Influenza Burden Among,Children in School, Daycare Settings 6Data Show FluMist May Reduce Seasonal Influenza Burden Among,Children in School, Daycare Settings 7Data Show FluMist May Reduce Seasonal Influenza Burden Among,Children in School, Daycare Settings 8Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats 2Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats 3Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats 4Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats 5Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats 6
Streck-Detergent III is a balanced electrolyte solution for use as a rinsing and hemoglobin blanking diluent. It is manufactured for the Abbott CELL-DYN® 1400, 1600, 3500 and 3700. The shelf life
An environmentally-safe, CN-free lytic reagent designed for use on the Abbott CELL-DYN® 1800 three-part differential hematology analyzer.
...us Retics is a 5-part differential control that co...r the Abbott CELL-DYN 3200, 3500, 3700 and 4000 in...ated red blood cells that can be analyzed and enum...tomated and manual reticulocyte values for all thr...
Para 12 Plus is a hematology control for the Abbott CELL-DYN 3000, 3200, and 3500/3700. Assay values are provided for the five-part white cell differential, as well as a three-part differential on th
Medicine Products: